Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
17.40
-0.26 (-1.47%)
At close: Sep 17, 2025, 4:00 PM EDT
17.74
+0.34 (1.95%)
After-hours: Sep 17, 2025, 4:30 PM EDT

Oculis Holding AG Revenue

Oculis Holding AG had revenue of 261.00K CHF in the quarter ending June 30, 2025, with 6.53% growth. This brings the company's revenue in the last twelve months to 764.00K, down -12.28% year-over-year. In the year 2024, Oculis Holding AG had annual revenue of 686.00K, down -22.31%.

Revenue (ttm)
764.00K CHF
Revenue Growth
-12.28%
P/S Ratio
947.93
Revenue / Employee
15,592 CHF
Employees
49
Market Cap
910.64M USD

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024686.00K-197.00K-22.31%
Dec 31, 2023883.00K-29.00K-3.18%
Dec 31, 2022912.00K-48.00K-5.00%
Dec 31, 2021960.00K-33.00K-3.32%
Dec 31, 2020993.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings